Signaling Pathways - Insulin and Insulin-like Receptors - Protease-Activated Receptors - Angiotensin AT2 Receptors - MARK1
清除全部
-
B2206 PD123319Target: Angiotensin AT2 ReceptorsSummary: 血管紧张素AT2受体的拮抗剂 -
A8809 Vorapaxar中文名: 沃拉帕沙Target: Protease-Activated ReceptorsSummary: PAR-1拮抗剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A8229 ML161Target: Protease-Activated ReceptorsSummary: PAR1抑制剂 -
A3704 PD 123319 ditrifluoroacetateTarget: Angiotensin AT2 ReceptorsSummary: 血管紧张素AT2受体拮抗剂 -
A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂